• Home
  • News
  • Analysis
  •  
    Regions
    • South Asia
    • North America
    • Europe
    • Central Asia
    • Australasia
    • MENA
    • Southeast Asia
    • Greater China
    • North Asia
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Credit
    • Early stage
    • PIPE
  •  
    Exits
    • Buyback
    • IPO
    • Open market
    • Trade sale
  •  
    Sectors
    • Real Estate
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      2023-china-216x305
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

China

China digital services player Deepexi raises $40m
China digital services player Deepexi raises $40m

Deepexi, a Chinese start-up that provides digital transformation solutions to enterprise customers, has raised $40 million in the fourth tranche of a Series A funding round.

  • Expansion
  • 15 December 2020
PE-backed Pop Mart posts strong gain after $674m HK IPO
PE-backed Pop Mart posts strong gain after $674m HK IPO

Pop Mart International Group, China’s largest fashion toy retailer, gained 79% on its Hong Kong trading debut following a HK$5.22 billion ($674 million) IPO.

  • Greater China
  • 14 December 2020
China healthtech player gets $100m Series C extension

Weimai, a Chinese healthcare-focused big data platform that primarily serves hospitals and clinics in lower-tier cities, has raised $100 million in an extended Series C round led by Baidu Capital.

  • Greater China
  • 14 December 2020
China VC: The naming of firms
China VC: The naming of firms

The process of coming up with a name for a venture capital firm in China can be fraught with challenges around linguistic and cultural differences as well as questions about brand and values

  • Greater China
  • 14 December 2020
Government funds back Chinese online grocer Miss Fresh

Chinese online grocer Miss Fresh has raised RMB2 billion ($305 million) from three Qingdao government-related funds to support expansion in the city on China's eastern seaboard.

  • Greater China
  • 11 December 2020
PE-backed Harbour BioMed raises $221m in Hong Kong IPO
PE-backed Harbour BioMed raises $221m in Hong Kong IPO

Harbour BioMed, a Chinese drug developer backed by the likes of Advantech Capital, Legend Capital and GIC, raised HK$1.71 billion ($221 million) through a Hong Kong IPO.

  • Greater China
  • 11 December 2020
LAV, Arch lead $100m round for China's SciNeuro
LAV, Arch lead $100m round for China's SciNeuro

SciNeuro Pharmaceuticals, a China and US-based drug developer specializing in treatments for central nervous system (CNS) disorders, has announced its formal launch with a $100 million funding round.

  • Greater China
  • 10 December 2020
ZWC hits $400m first close on China fund
ZWC hits $400m first close on China fund

Chinese venture capital firm ZWC Partners has completed a first close of $400 million on its second US dollar-denominated fund. The full target is $450 million.

  • Greater China
  • 10 December 2020
Fund focus: DCL targets China's unremitting debtors
Fund focus: DCL targets China's unremitting debtors

With $455 million in commitments for its latest renminbi fund, DCL Investments hopes to make its on-the-ground capabilities count in resolving China’s non-performing loans problem

  • Greater China
  • 09 December 2020
China HR software start-up GaiaWorks gets $76m Series D

China-based GaiaWorks, an workforce management software-as-a-service (SaaS) provider, has raised RMB500 million($76 million) in an extended Series D round led by GGV Capital.

  • Greater China
  • 09 December 2020
Asia travel & hospitality: Ready to board?
Asia travel & hospitality: Ready to board?

The outlook for international tourism remains uncertain, but this hasn’t stopped some private equity and venture capital investors targeting travel and hospitality assets in Asia. It pays to be selective

  • Greater China
  • 09 December 2020
China retail SaaS provider Huice secures $100m Series C
China retail SaaS provider Huice secures $100m Series C

Huice, a China-based provider of software for retailers, has raised nearly $100 million in Series C funding led by Singapore’s GIC. GL Ventures, Legend Capital and SoftBank Ventures Asia also participated in the round.

  • Greater China
  • 09 December 2020
Israel's OTV raises $170m, plans Asia expansion
Israel's OTV raises $170m, plans Asia expansion

OTV, an Israeli VC firm focused on digital health, has closed its latest fund at $170 million, opened a China office, and appointed a new head of Asia to spearhead an expansion in the region.

  • MENA
  • 08 December 2020
China's Snowball Finance raises $120m

Snowball Finance, a Chinese online financial information platform with wealth management ambitions, has raised $120 million Series E from Orchid Asia.

  • Greater China
  • 08 December 2020
China Everbright raises $459m for BRI fund
China Everbright raises $459m for BRI fund

China Everbright has reached a first close of RMB3 billion ($459 million) on an environment-focused fund that concentrates on economies covered by the Belt and Road Initiative (BRI).

  • Greater China
  • 07 December 2020
Deal focus: Speed pays off for Ince with Eeo

Ince Capital's $35 million investment in Eeo Education's Series B round is the largest from its debut fund. The GP has since re-upped in a $265 million Series C at twice the valuation

  • Greater China
  • 07 December 2020
Deal focus: Huaxing gives overseas LPs taste of China medtech
Deal focus: Huaxing gives overseas LPs taste of China medtech

In addition to raising $213 million for its latest renminbi-denominated fund, Huaxing Healthcare Capital sourced $230 million from co-investors for a succession deal in China’s orthopedics space

  • Greater China
  • 04 December 2020
Chinese EV maker Hozon raises $305m
Chinese EV maker Hozon raises $305m

Zhengjiang-based Electronic Vehicle (EV) start-up Hozon Auto has raised RMB2 billion ($305 million) from Huading Capital, a specialist EV investor.

  • Expansion
  • 04 December 2020
MBK credit fund to join PE fund on CAR investor roster

MBK Partners has agreed to subscribe to $175 million in convertible bonds issued by China Auto Rental (CAR). It follows a large commitment and a take-private offer by MBK last month.

  • Greater China
  • 04 December 2020
China's Chang Guang Satellite raises $376m
China's Chang Guang Satellite raises $376m

Chang Guang Satellite Technology, a China-based commercial satellite developer, has raised RMB2.46 billion ($376 million) in pre-IPO funding. It is the largest-ever funding round in China’s commercial aerospace industry.

  • Greater China
  • 03 December 2020
LP interview: Rockefeller University
LP interview: Rockefeller University

Rockefeller University has aggressively expanded its endowment program by ramping up its appetite for risk. Asian venture capital is playing a key role in this agenda

  • North America
  • 03 December 2020
China's Suning raises $912m for e-commerce services arm
China's Suning raises $912m for e-commerce services arm

Yunwang Wandian, the e-commerce services arm of Suning.com, one of China’s largest retailers, has raised a RMB6 billion ($912 million) Series A round led by Shenzhen Capital Group.

  • Early-stage
  • 02 December 2020
3W leads $43m Series E for China's CANbridge
3W leads $43m Series E for China's CANbridge

Hong Kong’s 3W Fund Management has led a $43 million Series E round for CANbridge Pharmaceuticals, a Beijing-based drug developer that focuses cancer and rare diseases.

  • Greater China
  • 02 December 2020
The big C: China biotech start-ups get cutting edge on cancer
The big C: China biotech start-ups get cutting edge on cancer

The evolution of cancer treatments in China is a bellwether for biotech development in the country and its capacity for genuine innovation. Most PE and VC investors aren’t shying away

  • Greater China
  • 02 December 2020
555657
  • About AVCJ
  • Advertise
  • Contacts
  • About ION Analytics
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013